Conclusions: Familial burden – in addition to age, sex, and specific LS gene – should be used to assess LS carriers’ risks of specific cancers and guide decision-making about organ-specific surveillance.
“Some say, ‘Oh, I don’t want to know.’ And I think, well, you’re nuts because knowledge is power, and you can stay ahead of this,”
Bren has Lynch Syndrome and is constantly trying to create awareness.
Before and after his scan…..
IS NOT finding out you have Cancer.
Finding out you have Lynch Syndrome…
IS A WAY TO PREVENT CANCER.
Better defined and individualized prospective probabilities of cancer may be needed for genetic counselling and planning of preventive interventions.